Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Shockwave Medical

J&J delivers Shockwave data sustaining below-the-knee gains for two years

By

Johnson & Johnson MedTech (NYSE: JNJ) shared extended clinical findings from its Shockwave intravascular lithotripsy system, from a study aimed at clearing calcified vessel blockages below the knee in patients with peripheral artery disease. In late-breaking data presented at the Vascular InterVentional Advances 2026 conference in Las Vegas, … [Read more...] about J&J delivers Shockwave data sustaining below-the-knee gains for two years

Johnson & Johnson begins carotid IVL study enrollment

By

Johnson & Johnson (NYSE:JNJ) today announced the initiation of its SKYWARD clinical program for a new Shockwave IVL system. The SKYWARD FDA investigational device exemption (IDE) study evaluates the novel SkyRunner carotid intravascular lithotripsy (IVL) system for the treatment of calcified carotid arteries prior to stenting. SkyRunner, … [Read more...] about Johnson & Johnson begins carotid IVL study enrollment

Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter

By

With its $13 billion acquisition of Shockwave Medical in 2024, Johnson & Johnson added the market leader in intravascular lithotripsy (IVL) to its portfolio. Since then, the company has continued to build on that leadership position with new product rollouts. That includes the recent launch of Shockwave C2 Aero, the latest catheter system … [Read more...] about Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter

Johnson & Johnson launches next-gen Shockwave IVL catheter

By

Johnson & Johnson (NYSE:JNJ) today announced the global launch of the Shockwave C2 Aero coronary intravascular lithotripsy (IVL) catheter. The next-generation catheter leverages Shockwave IVL's unique mechanism of action and the safety and effectiveness profile of its legacy catheters. It features improved deliverability, enhanced lesion … [Read more...] about Johnson & Johnson launches next-gen Shockwave IVL catheter

J&J’s Shockwave shares data supporting Javelin forward IVL

By

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results in a study using its Javelin peripheral IVL catheter. Yesterday, the company shared findings from a separate intravascular lithotripsy (IVL) study. It presented findings at the annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Today, it shared … [Read more...] about J&J’s Shockwave shares data supporting Javelin forward IVL

J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI

By

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral IVL system. Shockwave shared findings from DISRUPT BTK II. The post-market study evaluates the safety and effectiveness of the company's intravascular lithotripsy (IVL) system for the treatment of calcified lesions … [Read more...] about J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI

J&J’s Shockwave launches Javelin IVL catheter in Europe

By

Johnson & Johnson MedTech‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe. The novel, non-balloon catheter comprises part of the company's first-of-its-kind forward intravascular lithotripsy (IVL) platform. It features a similar safety and effectiveness profile to legacy Shockwave IVL … [Read more...] about J&J’s Shockwave launches Javelin IVL catheter in Europe

J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women

By

  Johnson & Johnson MedTech‘s Shockwave Medical unit today announced study results highlighting the use of its IVL treatment in female patients. Shockwave announced 30-day primary endpoint results from the EMPOWER CAD study of its intravascular lithotripsy (IVL) therapy. It marks the first prospective, real-world percutaneous … [Read more...] about J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women

J&J’s Shockwave enrolls first patient in novel forward IVL study

By

Johnson & Johnson MedTech‘s Shockwave Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter. FORWARD CAD, an FDA investigational device exemption (IDE) study, evaluates the safety and efficacy of the company's latest intravascular lithotripsy (IVL) catheter. It aims to treat calcified, … [Read more...] about J&J’s Shockwave enrolls first patient in novel forward IVL study

How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach

By

Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels. Johnson & Johnson MedTech’s Shockwave Medical aims to deliver intravascular lithotripsy (IVL) to a different type of blood vessel with a first-of-its-kind catheter platform. The Javelin … [Read more...] about How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach